Trial Profile
The efficacy and safety of subcutaneous injection of bortezomib combined with doxorubicin and dexamethasone for untreated multiple myeloma patients.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Apr 2012
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone; Doxorubicin
- Indications Multiple myeloma
- Focus Therapeutic Use
- 23 Apr 2012 New trial record